EFX EQUIFAX INC
Services-Consumer Credit Reporting, Collection Agencies · NYSE · SEC CIK 33185 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.9%
TTM net income YoY12.8%
TTM EPS YoY16.8%
Revenue 3-yr CAGR8.7%
Net income 3-yr CAGR12.5%
Margins
Gross margin55.2%
Operating margin18.8%
Net margin11.3%
FCF margin16.7%
EBITDA margin30.3%
Returns
ROE15.8%
ROA6.3%
ROIC (approx.)9.5%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets61.3%
Debt / equity1.16x
Current ratio1.09x
Interest coverage5.35x
Cash quality & payout
Operating cash flow / net income2.17x
Accruals ratio-7.3%
Payout ratio35.0%
Capex / revenue7.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $6.07B | $5.68B |
| Cost of revenue | $2.65B | $2.52B |
| Gross profit | $3.43B | $3.16B |
| SG&A expense | $1.61B | $1.45B |
| Operating income | $1.10B | $1.04B |
| Interest expense | $212.30M | $229.10M |
| Pretax income | $894.90M | $810.50M |
| Income tax | $230.60M | $203.20M |
| Net income | $660.30M | $604.10M |
| EBITDA | $1.82B | $1.72B |
| EPS (basic) | 5.36 | 4.88 |
| EPS (diluted) | 5.32 | 4.84 |
| Dividends declared per share | 1.89 | 1.56 |
| Weighted avg. shares (diluted) | 124.10M | 124.90M |
| Balance sheet | ||
| Cash & equivalents | $180.80M | $169.90M |
| Receivables | $1.01B | $957.60M |
| Current assets | $1.41B | $1.36B |
| PP&E, net | $1.93B | $1.89B |
| Goodwill | $6.75B | $6.55B |
| Intangibles | $1.33B | $1.52B |
| Total assets | $11.86B | $11.76B |
| Current liabilities | $2.34B | $1.81B |
| Short-term debt | $1.04B | $687.70M |
| Long-term debt | $4.06B | $4.32B |
| Total debt | $5.09B | $5.01B |
| Total liabilities | $7.13B | $6.84B |
| Shareholders' equity | $4.60B | $4.80B |
| Net debt | $4.91B | $4.84B |
| Shares outstanding | 120.40M | 124.00M |
| Cash flow statement | ||
| Operating cash flow | $1.62B | $1.32B |
| Capital expenditure | $481.40M | $511.50M |
| Free cash flow | $1.13B | $813.00M |
| Investing cash flow | -$554.30M | -$511.50M |
| Financing cash flow | -$1.06B | -$846.40M |
| Depreciation & amortization | $726.90M | $680.60M |
| Stock-based compensation | $78.40M | $81.60M |
| Dividends paid | $232.80M | $193.20M |
| Share buybacks | $927.50M | $0 |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.